BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE— 510(k) K870807

Name: FDA 510(k) clearance K870807
Creator: U.S. Food and Drug Administration
Published: 1987-05-29

Substantially Equivalent

Allergan, Inc.

FDA 510(k) clearance K870807 for BKS-1000 REFRACTIVE SET USE IN KERATOREFRACTIVE, Substantially Equivalent on 1987-05-29. Applicant: Allergan, Inc.. Device class: 1.

Clearance details

Applicant: Allergan, Inc.
Product code: Code HNO
Device class: Class 1
Regulation: 21 CFR 886.4370
Advisory panel: Ophthalmic
Date received: 1987-02-27
Decision date: 1987-05-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Santa Ana, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code HNO

view all

K173371 — VisuMax Femtosecond Laser2018-04-13
K172994 — EPI K Console2017-10-26
K072102 — EPIVISION SL SYSTEM2009-01-16
K082043 — CARRIAZO-PENDULAR MICROKERATOME2008-08-01
K062465 — ZYOPTIX XP EPI SEPARATOR SYSTEM2006-09-06

More clearances from Allergan, Inc.

view all

K190674 — REFRESH RELIEVA For CONTACTS2019-08-08
K161457 — XEN Glaucoma Treatment System2016-11-21
K143354 — Natrelle 133 Plus Tissue Expander2015-08-20
K083812 — REFRESH OPTIVE LENS COMFORT REWETTING DROPS2009-07-09
K051852 — SINGLE AMPLIFIER FOR BOTOX2005-09-14

Adverse events under product code HNO

product code HNO

Injury: 390
Total: 390

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.